Viruses like the one that causes COVID-19 constantly mutate, rendering many antibody treatments ineffective. A Stanford-led ...

Moderna (NASDAQ:MRNA) is targeting market approval of a personalized vaccine the company is developing with Merck (NYSE:MRK) ...

“Findings in this report show that vaccination with the 2024–2025 influenza vaccine reduced the likelihood of medically attended influenza and support CDC’s recommendation that all persons aged ≥6 ...

A German court on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held by Moderna .

A new study suggests Paxlovid may not reduce the risk of covid-19 hospitalizations and all-cause deaths in vaccinated adults ...

Shrewd investors know that bear markets open up great opportunities to pick up shares of excellent companies from the discount bin. However, even in a bull market, like the one we're currently ...

Novavax on Thursday posted a narrower fourth-quarter loss and said it expects its licensing deal with French drugmaker Sanofi ...

Imunon has reported new immunogenicity and safety data from its proof-of-concept Phase I trial’s ongoing analyses of the IMNN ...

Concerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday.

Veteran vaccine researcher Arturo Casadevall gives a podcast primer on vaccinations, from how they work on a molecular level to common misconceptions ...

NBA legend Jimmy Butler is bringing his passion for premium coffee to the Middle East as Big Face Coffee makes its debut in Dubai in partnership with the Delano hotel on Bluewaters Island.

Experts from Yale University have discovered an alarming syndrome linked to the mRNA Covid vaccines ... in immune cells and the presence of coronavirus proteins in their blood, years after ...